New

Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
ETF Central logo
Advertisement

XPHvsPSCHETF Comparison

ETF 1
XPH

SPDR S&P Pharmaceuticals ETF

This fund is part of
US Health Care
-1.91%
Full XPH fund page
VS
ETF 2
PSCH

Invesco S&P SmallCap Health Care ETF

This fund is part of
US Health Care
-1.91%
Full PSCH fund page

SPDR S&P Pharmaceuticals ETF (XPH) and Invesco S&P SmallCap Health Care ETF (PSCH) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. XPH is more expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.29% for PSCH. XPH is down -4.43% year-to-date (YTD) with +$88M in YTD flows. PSCH performs worse with -9.57% YTD performance, and -$14M in YTD flows. Run a side-by-side ETF comparison of XPH and PSCH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

XPH vs PSCH performance and flow charts

Performance

-6.0-4.0-2.00.02.04.0%Feb 12Feb 20Feb 27Mar 6

Cumulative Flows

-10 M-5 M0 M5 M10 M15 MFeb 12Feb 20Feb 27Mar 6

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 03/12/2026
1M3MYTD1Y3Y5Y
Perf.
XPH
PSCH
-5.57%-4.98%
-4.40%-13.47%
-4.43%-9.57%
+25.72%-4.84%
+38.19%-5.55%
+4.97%-37.27%
Flows
XPH
PSCH
+$12M-$12M
+$95M-$15M
+$88M-$14M
+$111M-$33M
+$48M-$168M
+$36M-$230M
Volatility and drawdown
3M1Y3Y5Y
Volatility
XPH
PSCH
+21.45%+19.05%
+23.32%+23.19%
+19.10%+21.52%
+20.31%+22.79%
Max drawdown
XPH
PSCH
-8.11%-13.93%
-17.10%-13.93%
-23.45%-23.50%
-33.10%-47.23%
Max drawdown duration
XPH
PSCH
15d80d
140d80d
322d449d
1706d1719d
Trading data

Create an account to view trading data

Join for free
XPH
PSCH
Last sale
3/12/2026 at 7:59 PM
$53.64
$40.01
Previous close
03/12/2026
$55.49
$41.15
Consolidated volume
03/12/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of February 27, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
XPH
PSCH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 3/12/2026 at 7:59 PM
Live
Closed
XPH
PSCH
Last price
$53.64
$40.01
1D performance
-3.33%
-2.76%
AuM$302.87 M$120.40 M
E/R0.35%0.29%
Characteristics
XPH
PSCH
Management strategyPassivePassive
ProviderSPDRInvesco
BenchmarkS&P Pharmaceuticals Select Industry IndexS&P SmallCap 600 Capped Health Care Index
N° of holdings4971
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateJune 19, 2006April 7, 2010
ESGNoNo
Advertisement
Exposure

Countries

XPH
USA
85.59%
Other
14.41%
PSCH
USA
95.98%
Other
4.02%

Sectors

XPH
Health Care
81.97%
Other
18.03%
PSCH
Health Care
91.17%
Other
8.83%

Diversification

XPH

Total weight of top 15 holdings out of 15

32.4%
PSCH

Total weight of top 15 holdings out of 15

43.5%

Top 15 holdings

Data as of January 31, 2026
XPH
LIQUIDIA CORPORATION
2.45%
US55287L1017
2.41%
AXSOME THERA CMN STK
2.33%
ORGANON & CO
2.25%
EDGEWISE THERAPEUTICS
2.24%
ELANCO ANIMAL HEALTH INC
2.13%
MERCK & CO INC
2.13%
VIATRIS INC
2.13%
AMNEAL PHARMACEUTICALS INC
2.12%
JOHNSON&JOHNSON
2.08%
ROYALTY PHARMA
2.06%
AMYLYX PHARMACEUTICALS
2.04%
BRISTOL-MYERS SQUIBB
2.03%
XERIS BIOPHARMA HOLDINGS INC
2.00%
ZOETIS INC
2.00%
PSCH
ARROWHEAD PHARMACEUTICALS INC
4.98%
KRYSTAL BIOTECH INC
3.88%
GLAUKOS
3.85%
PTC THERAPEUTI/D
3.30%
ALKERMES
2.95%
RADNET
2.78%
MERIT MEDICAL SYSTEMS
2.64%
PROTAGONIST THERAPEUTICS INC
2.61%
TRANSMEDICS GROUP
2.57%
TELEFLEX
2.48%
US10950A1060
2.46%
CORCEPT THERAPEUTICS
2.31%
US45579U1097
2.26%
TG THERAPEUTICS
2.25%
ADMA BIOLOGICS INC
2.18%
Frequently asked questions about XPH and PSCH

How have the XPH and PSCH ETFs performed in 2026?

As of March 12, 2026, XPH is down -4.43% year-to-date (YTD), while PSCH has lost -9.57%. That puts XPH better performer ahead so far this year.

Which ETF is attracting more investor money: XPH or PSCH?

Year-to-date, the XPH ETF saw +$88M in flows, compared to -$14M for PSCH.

Which ETF is more volatile: XPH or PSCH?

Over the past year, XPH had a volatility of 23.32%, while PSCH experienced 23.19%.

Which ETF is bigger: XPH or PSCH?

As of March 12, 2026, XPH holds $302.87 M in assets under management (AUM), while PSCH manages $120.40 M.

What sectors do the XPH and PSCH ETFs invest in?

XPH leans toward sectors like Health Care. Meanwhile, PSCH focuses on Health Care.

What are the top holdings of the XPH ETF and PSCH ETF?

XPH top holdings include LIQUIDIA CORPORATION, US55287L1017 and AXSOME THERA CMN STK. PSCH holds in its top three: ARROWHEAD PHARMACEUTICALS INC, KRYSTAL BIOTECH INC and GLAUKOS.

Which ETF is more diversified: XPH or PSCH?

XPH holds 57 securities with 32.4% of its assets in the top 15. PSCH has 75 securities and a top 15 weight of 43.5%.

Advertisement
Advertisement
Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up